"Brain's Resilience and Intelligence Networks (B.R.A.I.N.)" Seminar Series: Meditation as a mental training to promote healthy aging and prevent neurodegenerative diseases: the Medit-Ageing model

CONFERENCE 2020-07-16 00:00:00-2020-07-16 00:00:00 Online Meeting 16 July 2020   Organizer: Michael Ewers, Ph.D., Ludwig Maximilian University, Munich & German Center for Neurodegenerative Diseases (DZNE) Munich. Speaker: Gaël Chételat, PhD & Antoine Lutz, PhD, INSERM, France Meeting time: 11 AM ...


THERAPEUTICS Biogen IONIS Pharmaceuticals BIIB067 Ionis-SOD1Rx ASO1 DNA/RNA-based Other In January 2016, Biogen and Ionis began a Phase 1/2 safety trial in SOD1-ALS. The study enrolled 84 people who received single or multiple ascending doses by intrathecal injection ...

PAPER Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, Trudell R, Van Damme P, Zinman L, Bennett CF, Lane R, Sandrock A, Runz H, Graham D, Houshyar H, McCampbell A, Nestorov I, Chang I, McNeill M, Fanning L, Fradette S, Ferguson TA

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

N Engl J Med. 2020 Jul 9;383(2):109-119. PubMed: 32640130

Current Filters

  • Date Range : Jul 2019 to Jul 2020 x

Remove all filters

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From